Just saw Braidwell dumped like 1.78M Xenon shares last quarter—that's roughly $75M worth. Pretty significant move. Stock's hovering around $42 now, so they clearly took some losses on this one. They're down to 2.6% of their fund from what was probably a bigger position. Xenon's got Phase 3 data coming (or maybe already came by now?) for their seizure drug, and honestly this feels like they're derisking before we know if it actually works. The fund still holds 1.8M shares worth about $82M, so they didn't completely bail. That tells me they're not totally bearish on Xenon, just trimming exposure on what's basically a binary bet. Biotech is all about hitting those milestones—one good read-out and the stock could rip, one bad one and it tanks. Spreading risk across multiple shots on goal makes sense. You watching this one or too risky for your portfolio?